Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3244900 Title: FORMULATIONS PHARMACEUTIQUES COMPRENANT DU CANGRELOR DE HAUTE PURETÉ ET LEURS PROCÉDÉS DE PRÉPARATION ET D'UTILISATION

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
158782490
WO application number:
US2015039975
Type:
European patent granted for BE
Status:
Open
Publication number:
3244900
WO publication number:
WO2016114818
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
10/07/2015
Grant date:
03/06/2026
EP publication date:
22/11/2017
WO publication date:
21/07/2016
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
03/06/2026
EP B1 publication date:
03/06/2026
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
10/07/2035

Applicant

Name:
Chiesi Farmaceutici S.p.A.
Legal Form:
From:
03/06/2026
Address:
Via Palermo, 26/A, 43122 Parma, Italy (IT)
To:

Inventor

1

Name:
DUTTA, Panna
Legal Form:
Address:
Flemington, New Jersey 08822, United States (US)

2

Name:
RAFAI FAR, Adel
Legal Form:
Address:
Mount-Royal, Québec H3R 2X8, Canada (CA)

3

Name:
DING, Min
Legal Form:
Address:
Irvington, New York 10533, United States (US)

4

Name:
MOTHERAM, Rajeshwar
Legal Form:
Address:
Dayton, New Jersey 08810, United States (US)

Priority

Priority patent number:
201562103136 P
Priority date:
14/01/2015
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/7076; A61K 31/19; A61P 7/02; A61K 9/19;

Publication

European Patent Bulletin

Issue number:
202623
Publication date:
03/06/2026
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
03/08/2026
Annual fee number:
12
Annual fee amount:
240 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type